I'm new to OPXA but my reading of the news is that it's basically non-news at this point. So these Merck guys didn't want to buy OPXA's thing that failed in late October. That seems pretty obvious. So my take on the news is just confirmation of what was already expected. Any other takes on our pre-market news? OPXA hitting 1.02 after-hours, making me a little concerned as I'm long at 1.12. I'm thinking just MMs playing games.